ABOUT

Company Profile

Who we are

Biogene Biotechnology was founded by scientists who had spent years building libraries for plant and mammalian genomics. That origin still shapes how we work: every project is designed by someone who has run the experiment, not only quoted it.

Technology leadership in library construction

We have completed thousands of library projects. Our All-Direct technology builds cDNA libraries by one-step homologous recombination, avoiding restriction digestion and ligation entirely — the two steps most responsible for truncated genes in conventional workflows.

Compared with SMART-based methods, All-Direct avoids PCR amplification bias, preserving low-abundance and long transcripts. Compared with two-step Gateway cloning, it removes one round of recombination and amplification, which raises both capacity and average insert size.

Quality commitments

  • Primary library capacity above 1×10⁷ CFU, measured before any amplification
  • Positive rate above 98%, verified across 30,000 clones
  • Average insert size above 1200 bp, with a minimum above 1000 bp
  • Full QC package: capacity, insert distribution, empty-vector rate, colony and gel images

Beyond construction

We are one of the few providers in China that also runs screening. Bait cloning, auto-activation testing, yeast transformation, 3-AT optimisation, sequencing, BLAST analysis and retransformation validation are all performed in-house, so results are traceable from library to hit.

Need a tailored protocol?

Tell us your research goal and sample type. Our scientists will design the workflow and quote for you.

Request a quote